What Kreussler & Co. does

Kreussler & Co. (doing business as Kreussler Pharma) is a privately held German pharmaceutical manufacturer founded in 1948 and headquartered in Wiesbaden, Germany. The company is family-owned in its fourth generation, with more than 75 years of pharmaceutical manufacturing experience and a business heritage stretching back over 110 years. It develops, produces, and markets over-the-counter (OTC) pharmaceutical preparations concentrated in four therapeutic areas: oral healthcare, phlebology (vein disorders), proctology, and muscle/joint-related relaxation.

Its product portfolio includes branded OTC preparations such as DYNEXAN MUNDGEL, DYNEXIDIN FORTE, DEQUONAL, RECESSAN, DYNEXAMINFLUORID, Aethoxysklerol, and Phardol Thermo. All manufacturing is conducted at the company's Wiesbaden site. The company serves two primary customer segments: healthcare professionals (dentists, phlebologists, proctologists, general practitioners) and end consumers reached through pharmacies and dental channels. Its commercial model relies on prescription and OTC sales via pharmacy, dental, and selected distribution-partner channels; this is illustrated by the June 2026 partnership with Dermavon (德镒医药) to bring its portfolio into the Chinese market.

Geographically, more than two-thirds of revenue is generated outside Germany, with products distributed in over 70 countries. The workforce is stable — approximately 50% of employees have ten or more years of tenure — consistent with the operational profile of a mature, family-governed specialty pharmaceutical manufacturer.

Name

Kreussler & Co.

Legal name

Chemische Fabrik Kreussler & Co. GmbH

Website

https://kreussler-pharma.de

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

11–50 employees

Short description

Kreussler Pharma is a privately held, fourth-generation German pharmaceutical manufacturer producing OTC preparations in oral healthcare, phlebology, proctology, and muscle relaxation, distributed across more than 70 countries from its Wiesbaden production site.

Ownership category

akta.pro rank

Product category

OTC Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• OTC pharmaceuticals
• Oral healthcare products
• Sclerosing agents
• Phlebology treatments
• Proctology products

Headquarters

HQ city

Wiesbaden

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products (OTC Preparations): Sale of over-the-counter pharmaceutical preparations including oral health products (Dynexan Mundgel, Dequonal, Dynexidin Forte, Dynexaminfluorid Gelée), sclerosing agents (Aethoxysklerol), and other therapeutic products. Revenue is generated through pharmacy sales, direct healthcare professional sales, and international distribution via subsidiaries and partners. Over two-thirds of revenue is generated abroad.
2. Medical Devices and Cosmetics: Sale of medical devices and cosmetics in the oral healthcare, phlebology and proctology segments. These products complement the pharmaceutical portfolio and are sold through similar distribution channels including pharmacies and healthcare professionals.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Chemische Fabrik Kreussler & Co. GmbH (Kreussler Pharma) develops, produces and sells over-the-counter pharmaceutical preparations, medical devices and cosmetics in three therapeutic areas: oral healthcare (pain gels, antiseptic mouthwashes, fluoride prophylaxis), phlebology (sclerosing agents for spider veins, varicose veins and haemorrhoids), and movement/relaxation. Products are manufactured almost exclusively at the Wiesbaden site and distributed through pharmacies, direct healthcare professional channels, and international subsidiaries/sales partners across 70+ countries.

Product overview

Kreussler Pharma is a pharmaceutical company offering a portfolio of OTC preparations organized into three therapeutic areas: oral healthcare (pain relief gels, antiseptic mouthwashes, fluoride prophylaxis), phlebology (sclerosing agents for vein treatment), and proctology. The core oral health products include DYNEXAN MUNDGEL® (lidocaine-based pain gel), DYNEXIDIN® FORTE (chlorhexidine mouthwash), DEQUONAL® (antiseptic solution), RECESSAN® (polidocanol ointment), and DYNEXAMINFLUORID preparations (fluoride gel and varnish). For movement and relaxation, Phardol® Thermo provides warming relief. The phlebology/proctology portfolio centers on Aethoxysklerol®, a sclerosing agent available in multiple concentrations for treating spider veins, varicose veins, haemorrhoids, and oesophageal varices. Products are distributed internationally through own subsidiaries and sales partners, with production almost exclusively at the Wiesbaden site.

Differentiator

Problem solved

Functional benefit

Brands

• Dynexan: Oral health product line including Dynexan Mundgel (pain-relieving gel), Dynexidin Forte (mouthwash), and related oral care products
• Aethoxysklerol
• Dequonal
• Recessan
• Dynexaminfluorid
• Phardol Thermo

Products and services

• DYNEXAN MUNDGEL Pain-relieving oral gel containing lidocaine hydrochloride 20mg for temporary, symptomatic treatment of pain in oral mucosa, gums, and lips. Also available in cylinder ampoule form for intra-pocket anaesthesia without injection. Sold to consumers via pharmacies and to dental professionals for clinical use.
• DYNEXIDIN FORTE Chlorhexidine-based mouthwash (0.2%) for temporary reduction of bacteria in the oral cavity and supportive treatment of bacterial inflammation of gums and oral mucosa. Sold OTC through pharmacies.
• DEQUONAL Mouthwash and spray containing dequalinium chloride and benzalkonium chloride, effective against various viruses, bacteria and fungi for supportive treatment of oral mucosa inflammation and bad breath. Sold OTC through pharmacies.
• RECESSAN Highly adhesive analgesic ointment containing lauromacrogol 400 (polidocanol) 30mg for temporary, symptomatic treatment of painful inflammatory conditions of gums and oral mucosa. Sold OTC through pharmacies.
• DYNEXAMINFLUORID GELÉE Dental gel containing olaflur, dectaflur and sodium fluoride (1.25% total fluoride) for caries prevention, initial caries treatment, and treatment of hypersensitive tooth necks. Awarded Dental Growth Champion 2025.
• DYNEXAMINFLUORID LACK Fluoride varnish with four-way fluoridation for dental prophylaxis and caries protection, applied by dental professionals.
• DYNEXAN MUNDGEL Cylinder Ampoules Intra-pocket anaesthesia format of DYNEXAN MUNDGEL for pain-free dental procedures without injection, used by dental professionals during closed periodontal treatment.
• Phardol Thermo Topical product for exercise and relaxation providing soothing warmth to support muscle regeneration and enhance well-being. Sold OTC through pharmacies.
• Aethoxysklerol Sclerosing agent solution (0.25%, 0.5%, 1%, 2%, 3%) for sclerotherapy treatment of spider veins, varicose veins, haemorrhoids, and oesophageal varices. Causes vessel sealing and shrinkage through tissue reaction. Used by healthcare professionals (phlebologists, vascular surgeons, proctologists).

Quantifiable outcome

• Sclerotherapy with Aethoxysklerol achieves improvement rates of over 90% for spider veins and smaller varicose veins per medical guidelines
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature8 records

Partnerships

One partnership is on record.

• Dermavon (德镁医药)notableChannel Partner/ Reseller/ Distributor · 1 June 2026Dermavon is Kreussler Pharma's long-standing partner for the Chinese market. Dr. Philipp Göbel, Managing Director, travelled with Dermavon representatives to visit Shenyang, Beijing, Tianjin and Shanghai, meeting leading physicians including professors at Peking University hospitals and the Plastic Surgery Hospital of the Chinese Academy of Medical Science. Discussions focused on Aethoxysklerol's use for venous disease and haemorrhoid treatment in China. This partnership enables market presence in one of the world's most dynamic healthcare markets.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Galderma SA: Global pure-play dermatology and aesthetics pharmaceutical company covering prescription, OTC and aesthetic products. Overlaps with Kreussler's dermatology/aesthetics sclerosing agents and topical formulations, but at much larger scale and with broader portfolio.
• Haleon plc: Global consumer healthcare leader in oral health (Sensodyne, Corsodyl/chlorhexidine, Aquafresh), pain relief and wellness. Directly relevant via Corsodyl (chlorhexidine mouthwash competing with Dynexidin Forte/Dequonal) and broader OTC oral-care franchise.
• Stada Arzneimittel AG: Germany-headquartered pharmaceutical company with a large branded OTC and generics portfolio across many therapeutic areas. Comparable to Kreussler via its German pharma heritage and pharmacy-channel OTC model, though significantly larger and broader in product mix.
• Pfizer Inc. (Consumer Healthcare / Preparation H): Global pharmaceutical major with significant proctology (Preparation H) and broader consumer health OTC offerings. Comparable as an established branded OTC participant in the haemorrhoid category where Aethoxysklerol is registered.

Direct peers

• Dermapharm Holding SE: German specialty pharmaceutical company focused on branded OTC and prescription products in dermatology, allergy and women's health, with strong pharmacy distribution. Highly comparable to Kreussler as a mid-size German branded pharma operator selling OTC through pharmacies.
• Repha GmbH Biologische Arzneimittel: German mid-size pharma manufacturer specialising in branded prescription and OTC products including phytopharmaceuticals and specialty preparations. Comparable as a similarly sized German specialty pharma with branded portfolio and pharmacy distribution.
• Dr. August Wolff GmbH & Co. KG Arzneimittel: Independent German family-owned pharma specialising in gynecology, dermatology and OTC self-medication. Comparable in family-ownership model, German manufacturing footprint and branded OTC/women's health focus.
• Trommsdorff GmbH & Co. KG: Mid-size German family/pharmaceutical-owned manufacturer of branded OTC and Rx products in cardiology, dermatology and women's health. Closely comparable in size, German mid-market positioning and branded OTC specialty model.
• Mibe GmbH Arzneimittel: German mid-size pharmaceutical company developing and producing branded OTC and Rx products for self-medication and women's health. Directly comparable as a German specialty pharma manufacturer serving pharmacy channels.

Others

• SIGVARIS Group: Global leader in medical compression therapy for venous and lymphatic disease. Adjacent to Kreussler's phlebology franchise (Aethoxysklerol sclerotherapy) — a complementary rather than directly competing channel in vein care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php?id=61558467201946
• LinkedInlinkedin.com/company/kreussler-pharma
• Instagraminstagram.com/kreussler1912

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kreussler & Co.